MGF: Side Effects & Safety
Part of the MGF Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Overall Safety Profile
MGF is an endogenously produced splice variant of IGF-1, providing inherent biological compatibility. Its local action profile limits systemic side effects compared to exogenous IGF-1 or growth hormone. However, human safety data is extremely limited.
Reported Side Effects
- Injection site pain: Common with intramuscular injection, particularly into small muscle groups
- Possible hypoglycemia: Through IGF-1 pathway activity, though less likely than with systemic IGF-1
- Local swelling: At injection sites
Important Limitations
Most MGF research is preclinical. Human safety and efficacy data is essentially absent. Standard MGF's extremely short half-life raises practical challenges. The distinction between local and systemic effects of PEG-MGF is not well-characterized.
Potential Contraindications
- Active cancer (growth factor activity)
- Diabetes or hypoglycemia risk
- Pregnancy and breastfeeding